Enjoy complimentary customisation on priority with our Enterprise License!
Below are some of the key findings from the TNF inhibitors market research report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Get a FREE sample now!
TNF inhibitors have shown high efficacy in the treatment of various autoimmune disorders. Due to this high efficacy coupled with the growing prevalence of autoimmune disorders, the TNS inhibitors market pipeline is witnessing heavy investments. Various companies are focused on developing drugs to treat autoimmune disorders, with several being in the clinical trial stages. For instance, a monoclonal antibody TNF inhibitor approved for the treatment of ankylosing spondylitis is in Phase III stage of clinical trials for the treatment of juvenile rheumatoid arthritis (RA). Many of these pipeline drugs are expected to be launched during the forecast period, incrementing TNF inhibitors market size and driving the TNF inhibitors market growth.
The advent of biosimilars is one of the key TNF inhibitors market trends that will further stimulate market growth. Currently, the global TNF inhibitors market has five approved biologics. With many approved biologics nearing patent expiration, the market is witnessing an increase in the number of biosimilars. About 50 biosimilars are being developed for the treatment of various conditions, with a sizeable share for treatment of autoimmune disorders. Biosimilars are cost effective and are preferred due to their ease of access and similar efficacy to original biologics. Biosimilars get preferred treatment from regulatory authorities for their approval and launch, as they result in cost savings for the federal healthcare budget. Such approaches from regulatory authorities help in quick launch of these biosimilars, which drives the market growth. The TNF inhibitors market is expected to grow at a CAGR of almost 10% during the forecast period.
The TNF inhibitors market is moderately concentrated with a few key players occupying the majority of the market share. By offering a complete analysis of the market's competitive landscape and with information on the products offered by the companies, this TNF inhibitors industry analysis report is designed to aid clients identify and build new growth strategies.
The report offers a complete analysis of various companies including:
The Americas will lead the TNF inhibitors market share during the forecast period. Whereas, in terms of growth rate, the APAC region will witness a slightly faster momentum compared to the other regions.
TNF inhibitors for RA will account for the largest TNF inhibitors market share during the forecast period. Whereas, TNF inhibitors for psoriasis will witness the fastest growth rate. Additionally, the report will also provide an accurate prediction of the contribution of the various segments to the growth of the TNF inhibitors market size.
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: CUSTOMER LANDSCAPE
PART 07: GEOGRAPHIC LANDSCAPE
PART 08: MARKET SEGMENTATION BY INDICATION
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
PART 15: EXPLORE TECHNAVIO
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.